| Detected | Trial | Change |
|---|---|---|
| 2026-05-14 | NCT05981209 Elotuzumab, CC-92480, and Dexamethasone for the Treatment of Relapsed or Refractory… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-14 | NCT05981209 Elotuzumab, CC-92480, and Dexamethasone for the Treatment of Relapsed or Refractory… |
Enrollment reduced: 27 -> 12 participants |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05519085 | A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus… | Relapsed or Refractory Multiple Myeloma | Recruiting |
| NCT05552976 | A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone… | Relapsed or Refractory Multiple Myeloma | Active, Not Recruiting |
| Phase 2 | |||
| NCT06627751 | Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory… | Extramedullary Disease in Multiple Myeloma | Recruiting |
| Phase 1/2 | |||
| NCT07356154 | A Study of Revumenib and Mezigdomide in People With Leukemia | Leukemia | Recruiting |
| NCT06988488 | A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and… | Multiple Myeloma | Recruiting |
| NCT02343042 | Selinexor and Backbone Treatments of Multiple Myeloma Patients | Multiple Myeloma | Active, Not Recruiting |
| Phase 1 | |||
| NCT07105059 | A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma | Multiple Myeloma | Recruiting |
| NCT06121843 | A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene… | Multiple Myeloma | Recruiting |
| NCT06048250 | Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed… | Multiple Myeloma | Recruiting |
| NCT07032714 | Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma | Relapsed Refractory Multiple Myeloma (RRMM) | Recruiting |
| NCT07355335 | Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML | KMT2A-rearranged | Not Yet Recruiting |
| NCT05981209 | Elotuzumab, CC-92480, and Dexamethasone for the Treatment of Relapsed or Refractory… | Recurrent Multiple Myeloma | Active, Not Recruiting |